Prognostic value ofKRASgenotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease
Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, Antonella Dal Mas, Gino Coletti, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Corrado Ficorella, Enrico RicevVolume:
10
Language:
english
DOI:
10.1186/1741-7015-10-135
Date:
December, 2012
File:
PDF, 234 KB
english, 2012